ABBV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.25%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $70,989,822.24

AbbVie Insider Trading History Chart

AbbVie Share Price & Price History

^$160.40

▼ -2.15 (-1.32%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

From Banyan Hill Publishing | Ad

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details

AbbVie Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/20/2024	Nicholas Donoghoe	EVP	Sell	21,082	$176.30	$3,716,756.60	55,903
3/18/2024	Jeffrey Ryan Stewart	EVP	Sell	58,949	$178.79	$10,539,491.71	60,941
2/29/2024	Kevin K Buckbee	SVP	Sell	5,144	$176.65	$908,687.60	6,983
2/29/2024	Perry C Siatis	EVP	Sell	9,891	$177.39	$1,754,564.49	10,397
2/29/2024	Robert A. Michael	COO	Sell	68,879	$176.45	$12,153,699.55	98,645
2/28/2024	Richard A. Gonzalez	CEO	Sell	138,616	$177.27	$24,572,458.32	519,099
2/23/2024	Perry C Siatis	EVP	Sell	13,753	$177.51	$2,441,295.03	28,173
2/23/2024	Scott T. Reents	CFO	Sell	14,140	$177.44	$2,509,001.60	27,065
2/21/2024	Azita Saleki-Gerhardt	EVP	Sell	52,870	$173.71	$9,184,047.70	243,944
12/26/2023	Nicholas Donoghoe	EVP	Sell	2,912	$154.72	$450,544.64	55,903
7/31/2023	Richard A. Gonzalez	CEO	Sell	18,500	$149.15	$2,759,275.00	625,294
4/25/2023	Elaine K. Sorg	SVP	Sell	6,130	$165.00	$1,011,450.00	35,330
4/17/2023	Elaine K. Sorg	SVP	Sell	7,499	$161.67	$1,212,363.33	35,330
4/3/2023	Elaine K. Sorg	SVP	Sell	15,002	$160.03	$2,400,770.06	42,829
4/3/2023	Perry C Siatis	EVP	Sell	3,520	$160.00	$563,200.00	10,377
3/13/2023	Jeffrey Ryan Stewart	EVP	Sell	53,125	$152.28	$8,089,875.00	60,941
3/1/2023	Elaine K. Sorg	SVP	Sell	15,003	$155.00	$2,325,465.00	42,829
3/1/2023	Perry C Siatis	EVP	Sell	12,135	$153.08	$1,857,625.80	10,377
3/1/2023	Scott T. Reents	CFO	Sell	15,942	$153.08	$2,440,401.36	809
2/21/2023	Carrie C. Strom	SVP	Sell	28,541	$151.04	$4,310,832.64	37,921
2/17/2023	Azita Saleki-Gerhardt	EVP	Sell	25,000	$149.53	$3,738,250.00	233,208
2/17/2023	Roxanne S. Austin	Director	Sell	10,000	$150.50	$1,505,000.00	40,705
12/12/2022	Timothy J. Richmond	EVP	Sell	42,370	$163.44	$6,924,952.80	13,837
5/23/2022	Michael Severino	Vice Chairman	Sell	79,801	$150.90	$12,041,970.90	152,103
5/16/2022	Henry O Gosebruch	EVP	Sell	83,960	$155.00	$13,013,800.00	16,623
5/16/2022	Michael Severino	Vice Chairman	Sell	100,000	$154.45	$15,445,000.00	152,103
5/9/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.28	$15,028,000.00	152,103
5/6/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.81	$15,081,000.00	152,103
3/24/2022	Jeffrey Ryan Stewart	EVP	Sell	27,690	$159.20	$4,408,248.00
3/9/2022	Brian L. Durkin	VP	Sell	18,628	$150.01	$2,794,386.28
3/1/2022	Henry O Gosebruch	EVP	Sell	15,000	$148.26	$2,223,900.00
3/1/2022	Robert A. Michael	Vice Chairman	Sell	43,105	$148.25	$6,390,316.25
2/7/2022	Carrie C. Strom	SVP	Sell	2,396	$141.17	$338,243.32
12/20/2021	Brian L. Durkin	VP	Sell	11,790	$128.51	$1,515,132.90
12/17/2021	Laura J. Schumacher	Vice Chairman	Sell	181,670	$130.24	$23,660,700.80
12/15/2021	Jeffrey Ryan Stewart	EVP	Sell	2,152	$128.00	$275,456.00
12/13/2021	Elaine K. Sorg	SVP	Sell	6,458	$125.85	$812,739.30
12/9/2021	Richard A. Gonzalez	CEO	Sell	174,100	$123.23	$21,454,343.00
12/6/2021	Timothy J. Richmond	EVP	Sell	50,350	$120.00	$6,042,000.00
11/2/2021	Roxanne S. Austin	Director	Sell	51,844	$116.38	$6,033,604.72
8/23/2021	Carrie C. Strom	SVP	Sell	5,057	$120.00	$606,840.00	11,595

Urgent Nvidia Warning

From Altimetry | Ad

Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.

Click here to access…

SEC Filings (Institutional Ownership Changes) for AbbVie (NYSE:ABBV)

70.23% of AbbVie stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbbVie Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/9/2024	Fortis Capital Advisors LLC	7,749	$1.41M	0.6%	+17.4%	0.000%
5/9/2024	Private Management Group Inc.	2,738	$0.50M	0.0%	-2.7%	0.000%
5/9/2024	Tradewinds LLC.	7,078	$1.29M	1.1%	N/A	0.000%
5/9/2024	Souders Financial Advisors	21,003	$3.83M	0.6%	+582.1%	0.001%
5/9/2024	Foundry Partners LLC	2,780	$0.51M	0.0%	-15.6%	0.000%
5/9/2024	Angeles Wealth Management LLC	9,710	$1.77M	0.2%	+10.7%	0.001%
5/9/2024	State Board of Administration of Florida Retirement System	1,927,653	$351.03M	0.7%	+3.2%	0.109%
5/9/2024	Eagle Bay Advisors LLC	9,336	$1.70M	1.1%	-5.4%	0.001%
5/9/2024	TD Asset Management Inc	3,474,020	$632.62M	0.6%	+156.0%	0.197%
5/9/2024	Dearborn Partners LLC	221,872	$40.40M	1.7%	-26.6%	0.013%
5/9/2024	Pettyjohn Wood & White Inc.	49,764	$9.06M	1.8%	-0.5%	0.003%
5/9/2024	Endowment Wealth Management Inc.	2,201	$0.40M	0.3%	-4.3%	0.000%
5/9/2024	Miramar Capital LLC	102,077	$18.59M	4.6%	-1.2%	0.006%
5/9/2024	Rogco LP	8,916	$1.62M	0.7%	-41.7%	0.001%
5/9/2024	WP Advisors LLC	35,594	$6.48M	2.1%	-0.4%	0.002%
5/9/2024	Koshinski Asset Management Inc.	33,720	$6.14M	0.6%	+14.4%	0.002%
5/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	1,041,447	$189.65M	0.5%	+65.7%	0.059%
5/8/2024	Schneider Downs Wealth Management Advisors LP	1,759	$0.32M	0.1%	+12.9%	0.000%
5/8/2024	Taurus Asset Management LLC	6,307	$1.15M	0.1%	-13.1%	0.000%
5/8/2024	Edmond DE Rothschild Holding S.A.	20,110	$3.66M	0.1%	-18.9%	0.001%
5/8/2024	Doheny Asset Management CA	17,721	$3.23M	2.7%	+9.5%	0.001%
5/8/2024	Richard C. Young & CO. LTD.	13,890	$2.53M	0.3%	N/A	0.001%
5/8/2024	MAI Capital Management	370,850	$67.53M	0.7%	+7.0%	0.021%
5/8/2024	Sheets Smith Wealth Management	15,676	$2.86M	0.3%	-0.5%	0.001%
5/8/2024	Financial & Tax Architects LLC	35,405	$6.45M	1.8%	-4.7%	0.002%
5/8/2024	Bleakley Financial Group LLC	117,541	$21.40M	0.6%	+5.5%	0.007%
5/8/2024	Heritage Wealth Advisors	9,242	$1.68M	0.1%	-2.8%	0.001%
5/8/2024	Baron Wealth Management LLC	2,652	$0.48M	0.3%	+36.7%	0.000%
5/8/2024	Focused Wealth Management Inc	6,305	$1.15M	0.2%	+3.5%	0.000%
5/8/2024	ProShare Advisors LLC	1,283,596	$233.74M	0.6%	-3.8%	0.072%
5/8/2024	Cognios Beta Neutral Large Cap Fund LP	3,011	$0.55M	0.7%	-19.5%	0.000%
5/8/2024	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	387,587	$70.58M	0.5%	+0.2%	0.022%
5/8/2024	Avantax Advisory Services Inc.	133,677	$24.34M	0.2%	-3.7%	0.008%
5/8/2024	US Bancorp DE	2,593,981	$472.37M	0.7%	-0.5%	0.146%
5/8/2024	SP Asset Management LLC	227,781	$41.48M	3.9%	-0.8%	0.013%
5/8/2024	Addison Capital Co	8,323	$1.52M	0.8%	+3.6%	0.000%
5/8/2024	Hohimer Wealth Management LLC	1,273	$0.23M	0.1%	N/A	0.000%
5/8/2024	Isthmus Partners LLC	1,725	$0.31M	0.0%	-20.1%	0.000%
5/8/2024	Russell Investments Group Ltd.	1,076,991	$196.03M	0.3%	+1.9%	0.061%
5/8/2024	Cornerstone Planning Group LLC	3,404	$0.62M	0.2%	-8.4%	0.000%
5/8/2024	Qsemble Capital Management LP	29,762	$5.42M	1.2%	N/A	0.002%
5/8/2024	QRG Capital Management Inc.	269,734	$49.12M	0.6%	+1.4%	0.015%
5/8/2024	Watershed Private Wealth LLC	1,104	$0.20M	0.1%	N/A	0.000%
5/8/2024	Headlands Technologies LLC	1,551	$0.28M	0.1%	-54.0%	0.000%
5/8/2024	New Republic Capital LLC	3,613	$0.66M	0.4%	+2.2%	0.000%
5/8/2024	Williams Jones Wealth Management LLC.	71,316	$12.99M	0.2%	+0.2%	0.004%
5/8/2024	Delta Financial Advisors LLC	2,265	$0.41M	0.2%	+3.1%	0.000%
5/8/2024	Inspire Advisors LLC	1,476	$0.27M	0.0%	-6.2%	0.000%
5/8/2024	Thoroughbred Financial Services LLC	26,011	$4.74M	0.5%	-2.2%	0.001%
5/8/2024	Donoghue Forlines LLC	7,497	$1.37M	0.4%	+22.9%	0.000%
5/7/2024	Verus Capital Partners LLC	64,640	$11.77M	1.3%	+1.6%	0.004%
5/7/2024	Meeder Advisory Services Inc.	29,596	$5.39M	0.5%	+3.5%	0.002%
5/7/2024	Meeder Asset Management Inc.	26,689	$4.86M	0.3%	-81.3%	0.002%
5/7/2024	NorthRock Partners LLC	25,292	$4.61M	0.4%	+7.3%	0.001%
5/7/2024	Choate Investment Advisors	68,861	$12.54M	0.3%	-8.3%	0.004%
5/7/2024	Sfmg LLC	7,120	$1.30M	0.1%	-5.2%	0.000%
5/7/2024	Fiduciary Family Office LLC	9,755	$1.78M	0.7%	+3.2%	0.001%
5/7/2024	WNY Asset Management LLC	4,905	$0.89M	0.1%	+5.6%	0.000%
5/7/2024	Abbrea Capital LLC	32,462	$5.91M	0.8%	+0.7%	0.002%
5/7/2024	Sei Investments Co.	435,557	$79.32M	0.1%	-6.3%	0.025%
5/7/2024	GW Henssler & Associates Ltd.	164,123	$29.89M	1.8%	-1.6%	0.009%
5/7/2024	Bedel Financial Consulting Inc.	12,249	$2.23M	0.3%	-0.5%	0.001%
5/7/2024	Chilton Capital Management LLC	13,464	$2.45M	0.1%	-8.3%	0.001%
5/7/2024	Stonebrook Private Inc.	2,785	$0.51M	0.1%	+5.9%	0.000%
5/7/2024	Nixon Peabody Trust Co.	6,822	$1.24M	0.1%	-4.3%	0.000%
5/7/2024	Concurrent Investment Advisors LLC	48,803	$8.89M	0.4%	+8.3%	0.003%
5/7/2024	Significant Wealth Partners LLC	9,495	$1.73M	1.1%	+26.6%	0.001%
5/7/2024	Keudell Morrison Wealth Management	22,568	$4.11M	1.2%	-5.7%	0.001%
5/7/2024	Atomi Financial Group Inc.	13,047	$2.38M	0.2%	+6.8%	0.001%
5/7/2024	Anchor Capital Advisors LLC	95,863	$17.46M	0.5%	-10.6%	0.005%
5/7/2024	Reynders McVeigh Capital Management LLC	37,451	$6.82M	0.4%	-8.4%	0.002%
5/7/2024	Montag A & Associates Inc.	71,401	$13M	0.6%	+5.4%	0.004%
5/7/2024	TCI Wealth Advisors Inc.	16,379	$2.98M	0.3%	-3.9%	0.001%
5/7/2024	Redwood Wealth Management Group LLC	4,849	$0.88M	0.9%	-3.8%	0.000%
5/7/2024	WealthPLAN Partners LLC	42,735	$7.78M	0.8%	-25.1%	0.002%
5/7/2024	Keating Investment Counselors Inc.	5,290	$0.96M	0.3%	-42.4%	0.000%
5/7/2024	KCM Investment Advisors LLC	79,540	$14.48M	0.5%	+0.1%	0.004%
5/7/2024	Tectonic Advisors LLC	29,921	$5.45M	0.4%	+3.5%	0.002%
5/7/2024	Smithfield Trust Co	33,099	$6.04M	0.3%	+0.5%	0.002%
5/7/2024	Swiss National Bank	5,287,310	$962.82M	0.7%	-4.2%	0.299%
5/7/2024	NTV Asset Management LLC	38,199	$6.96M	1.1%	+1.0%	0.002%
5/7/2024	Mondrian Investment Partners LTD	915,903	$166.79M	2.3%	-5.4%	0.052%
5/7/2024	Forsta AP Fonden	442,562	$80.59M	0.7%	-2.4%	0.025%
5/7/2024	Hyman Charles D	29,585	$5.39M	0.3%	+2.7%	0.002%
5/7/2024	Avalon Trust Co	3,950	$0.72M	0.1%	-2.5%	0.000%
5/7/2024	Illinois Municipal Retirement Fund	152,283	$27.73M	0.4%	-18.3%	0.009%
5/7/2024	Lipe & Dalton	26,416	$4.81M	2.5%	-0.6%	0.001%
5/7/2024	Capital Wealth Planning LLC	9,614	$1.75M	0.0%	N/A	0.001%
5/7/2024	ClariVest Asset Management LLC	44,330	$8.07M	0.8%	-69.9%	0.003%
5/7/2024	Benedetti & Gucer Inc.	1,464	$0.27M	0.1%	N/A	0.000%
5/7/2024	Nvwm LLC	10,597	$1.93M	0.5%	-1.6%	0.001%
5/7/2024	Nelson Capital Management LLC	25,989	$4.73M	0.9%	+27.3%	0.001%
5/7/2024	Aull & Monroe Investment Management Corp	21,935	$3.99M	1.8%	-1.9%	0.001%
5/7/2024	Oppenheimer Asset Management Inc.	151,239	$27.54M	0.4%	-5.8%	0.009%
5/7/2024	Oppenheimer & Co. Inc.	150,363	$27.38M	0.5%	-3.1%	0.008%
5/7/2024	PFG Advisors	24,965	$4.55M	0.3%	-7.1%	0.001%
5/7/2024	Prospera Private Wealth LLC	6,458	$1.18M	0.8%	-25.7%	0.000%
5/7/2024	Guardian Asset Advisors LLC	4,729	$0.86M	0.7%	+1.9%	0.000%
5/7/2024	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	71,559	$13.03M	0.4%	+10.6%	0.004%
5/7/2024	Obermeyer Wood Investment Counsel Lllp	18,073	$3.29M	0.2%	+72.8%	0.001%

Data available starting January 2016

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Today's Range

Now: $160.40

$159.87

$162.87

50 Day Range

MA: $172.48

$159.62

$182.10

52 Week Range

Now: $160.40

$130.96

$182.89

Volume

5,906,428 shs

Average Volume

5,662,472 shs

Market Capitalization

$283.25 billion

P/E Ratio

47.60

Dividend Yield

3.79%

Beta

0.61

Who are the company insiders with the largest holdings of AbbVie?: AbbVie's top insider investors include:
Richard A Gonzalez (CEO)
Azita Saleki-Gerhardt (EVP)
Michael Severino (Vice Chairman)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Perry C Siatis (EVP)
Scott T Reents (CFO)
Henry O Gosebruch (EVP)
Timothy J Richmond (EVP)
Kevin K Buckbee (SVP)
Learn More about top insider investors at AbbVie.
Who are the major institutional investors of AbbVie?: AbbVie's top institutional shareholders include:
Bank of New York Mellon Corp — 1.12%
Swiss National Bank — 0.30%
Sumitomo Mitsui Trust Holdings Inc. — 0.25%
Raymond James & Associates — 0.24%
Nordea Investment Management AB — 0.23%
TD Asset Management Inc — 0.20%
Learn More about top institutional investors of AbbVie stock.
Which major investors are selling AbbVie stock?: In the previous quarter, ABBV stock was sold by these institutional investors:
Bank of New York Mellon Corp
Assenagon Asset Management S.A.
Stonegate Investment Group LLC
Nordea Investment Management AB
Swiss National Bank
Raymond James & Associates
Los Angeles Capital Management LLC
Mn Services Vermogensbeheer B.V.
Within the previous year, company insiders that have sold AbbVie company stock include:
Richard A Gonzalez (CEO)
Azita Saleki-Gerhardt (EVP)
Michael Severino (Vice Chairman)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Learn More investors selling AbbVie stock.
Which major investors are buying AbbVie stock?: In the previous quarter, ABBV stock was acquired by institutional investors including:
TD Asset Management Inc
Global Assets Advisory LLC
BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Mitsubishi UFJ Asset Management Co. Ltd.
Mediolanum International Funds Ltd
Jennison Associates LLC
Svenska Handelsbanken AB publ
Mesirow Financial Investment Management Inc.

This 1 Biotech Stock has been shocking the markets

From Huge Alerts | Ad

Save the Date: BioStem's 2024 Q1 Call Coming Up!